Back

Characteristics and prognosis of wild-type transthyretin cardiac amyloidosis patients diagnosed before 65 years old

31 August 2025 (15:10 - 15:20)
Organised by: Logo
Congress Presentation Part of: Transthyretin cardiac amyloidosis Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Damien Guijarro

University hospitals of Geneva, Geneva (Switzerland)

5 More presentations in this session

Presentation thumbnail
Comparison of phenotype and prognosis of hereditary Val122Ile and wild type transthyretin cardiomyopathy.
Professor J. Inamo (Fort de France, MQ)
Abstract Slides Video
Presentation thumbnail
Neurological and cardiological profiling of patients with mutated transthyretin amyloidosis
Doctor L. Ordine (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Overtture study: disease burden at diagnosis in ATTR amyloidosis patients with cardiac impairment in Spain
Doctor P. Garcia-Pavia (Majadahonda, ES)
Abstract Slides Video
Presentation thumbnail
Screening for amyloid cardiomyopathy in patients with aortic stenosis
Doctor I. Mattig (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Targeted deployment of AI-ECG for efficient screening of transthyretin amyloid cardiomyopathy using deep learning representations of longitudinal electronic health records
Doctor E. Oikonomou (New Haven, US)
Abstract Slides Video

Access the full session

Session thumbnail
Transthyretin cardiac amyloidosis
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 15:10 CET
You may be interested in
thumbnail
Congress Session
Transthyretin cardiac amyloidosis
thumbnail
Congress Presentation
Comparison of phenotype and prognosis of hereditary Val122Ile and wild type transthyretin cardiomyopathy.
thumbnail
Congress Session
Cardiac amyloidosis from epidemiology to treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources